Ambrisentan
Side effects
Options:
Hide MedDRA Preferred Terms
MedDRA Preferred Term
|
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
1
|
2
|
3
|
4
|
5
|
6
|
Oedema peripheral
|
Oedema peripheral
|
17.2% - 28.4%
|
10.6%
|
x
|
x
|
x
|
x
|
x
|
x
|
Headache
|
Headache
|
very common, 14.6% - 19.4%
|
13.6%
|
x
|
|
x
|
x
|
x
|
x
|
Sinus headache
|
Sinus headache
|
very common
|
|
|
|
x
|
x
|
x
|
|
Migraine
|
Migraine
|
very common
|
|
|
|
x
|
x
|
x
|
|
Dizziness
|
Dizziness
|
postmarketing, 6.92% - 8.96%
|
9.85%
|
|
x
|
x
|
x
|
x
|
x
|
Syncope
|
|
|
|
|
x
|
|
|
|
Cough
|
Cough
|
5.38% - 7.46%
|
6.06%
|
|
|
|
x
|
x
|
x
|
Upper respiratory tract infection
|
Upper respiratory tract infection
|
4.62% - 7.46%
|
6.06%
|
|
|
|
x
|
x
|
x
|
Nasal congestion
|
Nasal congestion
|
common, 5.38% - 10.4%
|
1.52%
|
x
|
x
|
x
|
x
|
x
|
x
|
Dyspnoea
|
Dyspnoea exacerbated
|
1.49% - 7.69%
|
6.06%
|
|
|
|
x
|
x
|
x
|
Dyspnoea
|
postmarketing, 4.21% - 5.38%
|
3.03%
|
x
|
|
x
|
x
|
x
|
x
|
Asthenia
|
Fatigue
|
postmarketing, 4.48% - 5.38%
|
4.55%
|
|
x
|
x
|
x
|
x
|
|
Asthenia
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
|
Fatigue
|
Fatigue
|
postmarketing, 4.48% - 5.38%
|
4.55%
|
|
x
|
x
|
x
|
x
|
|
Palpitations
|
Palpitations
|
common, 3.85% - 4.6%
|
2.27%
|
x
|
|
x
|
x
|
x
|
x
|
Nausea
|
Nausea
|
postmarketing, 3.85% - 4.48%
|
9.09%
|
|
x
|
x
|
x
|
x
|
x
|
Constipation
|
Constipation
|
common, 3.08% - 5.97%
|
1.52%
|
x
|
|
x
|
x
|
x
|
x
|
Flushing
|
Flushing
|
common, 1.49% - 3.85%
|
0.758%
|
x
|
x
|
x
|
x
|
x
|
x
|
Epistaxis
|
Epistaxis
|
1.54% - 5.97%
|
3.79%
|
|
|
x
|
x
|
x
|
|
Nasopharyngitis
|
Nasopharyngitis
|
common, 2.99% - 5.38%
|
0.758%
|
x
|
|
x
|
x
|
x
|
x
|
Sinusitis
|
Sinusitis
|
common, 3.07% - 4.48%
|
0%
|
x
|
x
|
x
|
x
|
x
|
x
|
Abdominal pain
|
Abdominal pain
|
common, 2.99% - 3.08%
|
0.758%
|
x
|
|
x
|
x
|
x
|
x
|
Gastrointestinal pain
|
Abdominal pain
|
common, 2.99% - 3.08%
|
0.758%
|
x
|
|
x
|
x
|
x
|
x
|
Bronchitis
|
Bronchitis
|
1.49% - 4.62%
|
3.79%
|
|
|
|
x
|
x
|
|
Chest pain
|
Chest pain
|
1.49% - 4.62%
|
2.27%
|
|
|
x
|
x
|
x
|
x
|
Chest discomfort
|
|
|
|
|
|
|
|
x
|
Right ventricular failure
|
Right ventricular failure
|
1.49% - 4.62%
|
12.1%
|
|
|
|
x
|
x
|
x
|
Aspartate aminotransferase increased
|
Aspartate aminotransferase increased
|
1.54% - 2.99%
|
3.79%
|
|
|
|
x
|
x
|
|
Insomnia
|
Insomnia
|
1.49% - 2.31%
|
3.03%
|
|
|
|
x
|
x
|
x
|
Arthralgia
|
Arthralgia
|
0.769% - 2.99%
|
3.79%
|
|
|
|
x
|
x
|
x
|
Musculoskeletal discomfort
|
Arthralgia
|
0.769% - 2.99%
|
3.79%
|
|
|
|
x
|
x
|
x
|
Myalgia
|
|
|
|
|
|
|
|
x
|
Urinary tract infection
|
Urinary tract infection
|
1.49% - 1.54%
|
6.06%
|
|
|
|
x
|
x
|
|
Pulmonary hypertension
|
Pulmonary hypertension
|
0.769% - 1.49%
|
5.3%
|
x
|
|
|
x
|
x
|
x
|
Dermatitis
|
Rash
|
postmarketing, uncommon
|
|
|
x
|
x
|
x
|
x
|
x
|
Rash
|
Rash
|
postmarketing, uncommon
|
|
|
x
|
x
|
x
|
x
|
x
|
Hypersensitivity
|
Hypersensitivity
|
postmarketing, uncommon
|
|
|
x
|
x
|
x
|
x
|
x
|
Anaemia
|
Anaemia
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
x
|
Angioedema
|
Angioedema
|
postmarketing
|
|
|
x
|
x
|
|
|
x
|
Gastrointestinal disorder
|
Gastrointestinal disorder
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
Cardiac disorder
|
Cardiac disorder
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
Cardiac failure
|
Cardiac failure
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
|
Hepatitis
|
Hepatitis
|
postmarketing
|
|
|
x
|
|
|
|
|
Mediastinal disorder
|
Mediastinal disorder
|
postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
Nervous system disorder
|
Nervous system disorder
|
postmarketing
|
|
|
|
x
|
x
|
x
|
|
Vomiting
|
Vomiting
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
|
Hepatic failure
|
Hepatic failure
|
postmarketing
|
|
|
x
|
|
|
|
|
Liver injury
|
Liver injury
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
|
Traumatic liver injury
|
Liver injury
|
postmarketing
|
|
|
x
|
x
|
x
|
x
|
|
Hepatotoxicity
|
Hepatotoxicity
|
postmarketing
|
|
|
x
|
|
|
|
|
Autoimmune hepatitis
|
Autoimmune hepatitis
|
postmarketing
|
|
|
|
x
|
x
|
x
|
|
Hepatobiliary disease
|
Hepatobiliary disease
|
postmarketing
|
|
|
|
x
|
x
|
x
|
|
Hepatic congestion
|
Hepatic congestion
|
postmarketing
|
|
|
x
|
|
|
|
|
Fluid retention
|
Fluid retention
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Transaminases increased
|
Transaminases increased
|
postmarketing
|
|
|
|
x
|
x
|
x
|
|
Angina pectoris
|
Angina pectoris
|
|
|
|
|
|
|
|
x
|
Decreased appetite
|
Anorexia
|
|
|
|
|
|
|
|
x
|
Mental disorder
|
Mental disorder
|
|
|
|
|
|
|
|
x
|
Breast disorder
|
Breast disorder
|
|
|
|
|
|
|
|
x
|
Infection
|
Infection
|
|
|
|
|
|
|
|
x
|
Contusion
|
Contusion
|
|
|
|
|
|
|
|
x
|
Diarrhoea
|
Diarrhoea
|
|
|
|
|
x
|
|
|
x
|
Oedema
|
Oedema
|
|
|
|
|
|
|
|
x
|
Body temperature increased
|
Body temperature increased
|
|
|
|
|
|
|
|
x
|
Gastritis
|
Gastritis
|
|
|
|
|
|
|
|
x
|
Blood disorder
|
Blood disorder
|
|
|
|
|
|
|
|
x
|
Haemorrhage
|
Haemorrhage
|
|
|
|
|
|
|
|
x
|
Haemoglobin
|
Haemorrhage
|
|
|
|
|
|
|
|
x
|
Hypokalaemia
|
Hypokalaemia
|
|
|
|
|
|
|
|
x
|
Hypotension
|
Hypotension
|
|
|
|
|
x
|
|
|
|
Immune system disorder
|
Immune system disorder
|
|
|
|
|
x
|
x
|
x
|
x
|
Influenza
|
Influenza
|
|
|
|
|
|
|
|
x
|
Muscle spasms
|
Cramp muscle
|
|
|
|
|
|
|
|
x
|
Nocturia
|
Nocturia
|
|
|
|
|
|
|
|
x
|
Pharyngitis
|
Pharyngitis
|
|
|
|
|
|
|
|
x
|
Pleural effusion
|
Pleural effusion
|
|
|
|
|
|
|
|
x
|
Pneumonia
|
Pneumonia
|
|
|
|
|
|
|
|
x
|
Pruritus
|
Pruritus
|
|
|
|
|
x
|
|
|
x
|
Pulmonary oedema
|
Pulmonary oedema
|
|
|
|
x
|
|
|
|
|
Pulmonary veno-occlusive disease
|
Pulmonary veno-occlusive disease
|
|
|
|
x
|
|
|
|
|
Rales
|
Rales
|
|
|
|
|
|
|
|
x
|
Rhinitis
|
Rhinitis
|
|
|
|
|
x
|
|
|
x
|
Skin ulcer
|
Skin ulcer
|
|
|
|
|
|
|
|
x
|
Shock
|
Syncope
|
|
|
|
|
x
|
|
|
|
Syncope
|
Syncope
|
|
|
|
|
x
|
|
|
|
Loss of consciousness
|
Syncope
|
|
|
|
|
x
|
|
|
|
Tachycardia
|
Tachycardia
|
|
|
|
|
|
|
|
x
|
Urethral disorder
|
Urinary tract disorder
|
|
|
|
|
|
|
|
x
|
Urinary tract disorder
|
Urinary tract disorder
|
|
|
|
|
|
|
|
x
|
Angiopathy
|
Angiopathy
|
|
|
|
|
x
|
x
|
x
|
|
Wheezing
|
Wheezing
|
|
|
|
|
|
|
|
x
|
Haemoglobin decreased
|
Haemoglobin decreased
|
|
|
|
|
x
|
x
|
x
|
x
|
Malnutrition
|
Malnutrition
|
|
|
|
|
|
|
|
x
|
Myalgia
|
Myalgia
|
|
|
|
|
|
|
|
x
|
Abdominal pain upper
|
Abdominal pain upper
|
|
|
|
|
|
|
|
x
|
Discomfort
|
Discomfort
|
|
|
|
|
x
|
|
|
|
Chest discomfort
|
Chest discomfort
|
|
|
|
|
|
|
|
x
|
Non-cardiac chest pain
|
Non-cardiac chest pain
|
|
|
|
|
|
|
|
x
|
Haematocrit decreased
|
Haematocrit decreased
|
|
|
|
|
x
|
|
|
x
|
Infestation
|
Infestation NOS
|
|
|
|
|
|
|
|
x
|
Sleep disorder
|
Sleep disorder
|
|
|
|
|
|
|
|
x
|
Sperm concentration decreased
|
Sperm count decreased
|
|
|
|
x
|
|
|
|
|
Vaginal haemorrhage
|
Vaginal haemorrhage
|
|
|
|
|
|
|
|
x
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 12 |
Source: | FDA |
---|
Side effects: | 23 |
Source: | FDA Structured Product Label |
---|
Side effects: | 44 |
Source: | EMA |
---|
Side effects: | 46 |
Source: | medicines.org.au |
---|
Side effects: | 46 |
Source: | Medsafe |
---|
Side effects: | 65 |
Source: | Health Canada |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|